{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Science Desk;", "lead_paragraph": "SCIENTISTS have announced with great fanfare that a substance discovered a year ago preserves and restores two kinds of nerve cells, one in the brain and one in the spinal cord that activates muscle movements. Called glial cell-derived neurotrophic factor, or G.D.N.F., the molecule was discussed in four research papers in the current issue of the journal Nature.", "headline": {"main": "Substance Hailed as Tool to Fight Neurodegenerative Disease"}, "abstract": null, "print_page": "3", "word_count": 1442, "_id": "4fd1c66e8eb7c8105d6f7575", "snippet": "SCIENTISTS have announced with great fanfare that a substance discovered a year ago preserves and restores two kinds of nerve cells, one in the brain and one in the spinal cord that activates muscle movements.   Called glial cell-derived neurotrophic...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1995/01/31/science/substance-hailed-as-tool-to-fight-neurodegenerative-disease.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF)"}, {"name": "subject", "value": "NERVES AND NERVOUS SYSTEM"}, {"name": "subject", "value": "PARKINSON'S DISEASE"}, {"name": "subject", "value": "AMYLOTROPHIC LATERAL SCLEROSIS"}, {"name": "subject", "value": "BIOTECHNOLOGY"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Sandra", "lastname": "BLAKESLEE"}], "original": "By SANDRA BLAKESLEE"}, "document_type": "article", "pub_date": "1995-01-31T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "Calling an early halt to a national trial because of promising results, doctors today announced the first treatment for sickle cell anemia that attacks the underlying cause of the disease rather than simply combating its painful symptoms. The National Institutes of Health said it was issuing a clinical alert to thousands of doctors nationwide informing them that the drug hydroxyurea should be considered for many adult patients with the crippling blood disease. The institutes had sponsored the trial of the drug at nearly two dozen centers to see if it could reduce the painful episodes characteristic of the disease, which in this country primarily afflicts African-Americans.", "headline": {"main": "Sickle Cell Trial Called Success, Halted Early"}, "abstract": null, "print_page": "1", "word_count": 1234, "_id": "4fd1f9a38eb7c8105d756c85", "snippet": "Calling an early halt to a national trial because of promising results, doctors today announced the first treatment for sickle cell anemia that attacks the underlying cause of the disease rather than simply combating its painful symptoms.   The...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1995/01/31/science/sickle-cell-trial-called-success-halted-early.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "NATIONAL INSTITUTES OF HEALTH"}, {"name": "subject", "value": "HYDROXYUREA (DRUG)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "SICKLE CELL ANEMIA"}, {"name": "subject", "value": "TESTS AND TESTING"}], "byline": {"person": [{"firstname": "Warren", "middlename": "E.", "lastname": "LEARY", "rank": 1, "role": "reported", "organization": ""}], "original": "By WARREN E. LEARY"}, "document_type": "article", "pub_date": "1995-01-31T00:00:00Z", "section_name": "Science; Health"}], "meta": {"hits": 2, "offset": 0, "time": 32}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}